down arrow

Source Natural

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE679C01027
  • NSEID:
  • BSEID: 531398
INR
180.00
-2.95 (-1.61%)
BSENSE

Apr 11, 12:49 PM

BSE+NSE Vol: 254

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

176.55191.95

52 Week

78.00269.75
Valuation
Technical
Day's Volume

CASH

254 (-66.81%) Volume

Shareholding (Mar 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

74.37%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Mildly Bearish range

  • The technical trend has deteriorated from Sideways on 09-Apr-25 and has generated -1.61% returns since then
  • A key technical factor - KST has been Bearish since 09 Apr 2025
2

With ROE of 12.6, it has a Expensive valuation with a 5.7 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 120 Cr (Micro Cap)

stock-summary
P/E

45.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

12.62%

stock-summary
Price to Book

5.68

Revenue and Profits (1 Year):
Net Sales:
10 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-19.66%
0%
-19.66%
1 Year
100.13%
0%
100.13%
2 Years
82.02%
0%
82.02%
3 Years
74.59%
0%
74.59%
4 Years
15.83%
0%
15.83%
5 Years
137.15%
0%
137.15%

Source Natural for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
22.39%
EBIT Growth (5y)
27.03%
EBIT to Interest (avg)
3.45
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.29
Tax Ratio
32.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.17%
ROE (avg)
17.97%
Valuation key factors
Factor
Value
P/E Ratio
45
Industry P/E
33
Price to Book Value
5.68
EV to EBIT
26.49
EV to EBITDA
21.46
EV to Capital Employed
5.98
EV to Sales
3.26
PEG Ratio
30.49
Dividend Yield
NA
ROCE (Latest)
23.03%
ROE (Latest)
12.62%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sriveda Sattva Private Limited (74.37%)

Highest Public shareholder

Guttikonda Vara Lakshmi (2.96%)

Individual Investors Holdings

19.98%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 1.85% vs 25.74% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 21.43% vs 100.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.45",
          "val2": "10.26",
          "chgp": "1.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.66",
          "val2": "1.38",
          "chgp": "20.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.18",
          "chgp": "11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.02",
          "val2": "0.84",
          "chgp": "21.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.89%",
          "val2": "13.45%",
          "chgp": "2.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 47.63% vs 60.49% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 173.91% vs -39.47% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.41",
          "val2": "12.47",
          "chgp": "47.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.26",
          "val2": "1.23",
          "chgp": "83.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.09",
          "chgp": "188.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.26",
          "val2": "0.46",
          "chgp": "173.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.28%",
          "val2": "9.86%",
          "chgp": "2.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 40.99% vs 58.19% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 60.56% vs 40.59% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28.86",
          "val2": "20.47",
          "chgp": "40.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.92",
          "val2": "2.99",
          "chgp": "31.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.46",
          "val2": "0.15",
          "chgp": "206.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.28",
          "val2": "1.42",
          "chgp": "60.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.58%",
          "val2": "14.61%",
          "chgp": "-1.03%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 38.09% vs -8.13% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -17.92% vs -12.76% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27.30",
          "val2": "19.77",
          "chgp": "38.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.47",
          "val2": "3.56",
          "chgp": "25.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.21",
          "val2": "0.24",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.05",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.74",
          "val2": "2.12",
          "chgp": "-17.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.37%",
          "val2": "18.01%",
          "chgp": "-1.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
10.45
10.26
1.85%
Operating Profit (PBDIT) excl Other Income
1.66
1.38
20.29%
Interest
0.20
0.18
11.11%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.02
0.84
21.43%
Operating Profit Margin (Excl OI)
15.89%
13.45%
2.44%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 1.85% vs 25.74% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 21.43% vs 100.00% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
18.41
12.47
47.63%
Operating Profit (PBDIT) excl Other Income
2.26
1.23
83.74%
Interest
0.26
0.09
188.89%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.26
0.46
173.91%
Operating Profit Margin (Excl OI)
12.28%
9.86%
2.42%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 47.63% vs 60.49% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 173.91% vs -39.47% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
28.86
20.47
40.99%
Operating Profit (PBDIT) excl Other Income
3.92
2.99
31.10%
Interest
0.46
0.15
206.67%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.28
1.42
60.56%
Operating Profit Margin (Excl OI)
13.58%
14.61%
-1.03%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 40.99% vs 58.19% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 60.56% vs 40.59% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
27.30
19.77
38.09%
Operating Profit (PBDIT) excl Other Income
4.47
3.56
25.56%
Interest
0.21
0.24
-12.50%
Exceptional Items
-0.05
0.00
Standalone Net Profit
1.74
2.12
-17.92%
Operating Profit Margin (Excl OI)
16.37%
18.01%
-1.64%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 38.09% vs -8.13% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -17.92% vs -12.76% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Source Natural Foods & Herbal Supplements Ltd stock-summary
stock-summary
Source Natural Foods & Herbal Supplements Ltd
Micro Cap
Pharmaceuticals & Drugs
Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995. The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12. The Company engages in the pharmaceutical business in India. It provides allopathic and ayurvedic formulations. Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets.
Company Coordinates stock-summary
Company Details
201 2nd Floor Sumeru Towers, 54/46 39 Jayanagar 4th Block Bangaluru Karnataka : 560041
stock-summary
Tel: 91-80-26087733
stock-summary
http://www.source-natural.com
stock-summary
info@source-natural.com
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."